Trial Profile
HSV-1 Suppression in HCV Infected Veterans Who Are Seronegative for HSV-2
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms HSV1/HCV
- 12 May 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.
- 17 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2014 to 1 Mar 2015.
- 17 Jan 2014 Planned End Date changed from 1 Apr 2014 to 1 Sep 2014 as per ClinicalTrials.gov.